Join
Live feed
·
PRReleasevia Quantisnow
Cingulate Inc. logo
VectivBio Holding AG logo

Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CING (Cingulate Inc.), VECT (VectivBio Holding AG) and more on Quantisnow.